PHARMACOVIGILANCE

Serious side effects force a third of diabetics to quit...

  The side effects of the world's most commonly-prescribed diabetes drug are so severe that around a third of patients stop taking it, a new study has...

Half of over-65s taking five or more prescription drugs a...

Half the population of over-65s is taking at least five different prescription drugs every day, and some are taking as many as 23, a new study has discovered. The...

Regulator hid dangers of epilepsy drug for 40 years

    Drug regulators knew an epilepsy drug could cause birth abnormalities if a woman took it while she was pregnant, but didn't alert the public...

Young women still being prescribed thalidomide

Thalidomide, the morning sickness drug that caused appalling birth defects in more than 10,000 babies in the 1960s, is still being prescribed to young women who become pregnant—and three women...

Someone takes a drug wrongly every 21 seconds (that's 10.5...

Pharmaceuticals are dangerous enough as it is—but when they're taken incorrectly, they can be lethal. It's a common problem, with someone in the US reporting a serious medication error every...

Depression overdiagnosed by questionnaire developed by drug company

People are being diagnosed with depression with a simplistic point-scoring questionnaire that was developed by the drug company that has some of the leading antidepressant brands, and so is most...

One in three new drugs have serious—and sometimes deadly—safety issues

There's something seriously wrong with our drug approval processes. One in three drugs that pass all the usual checks before being given a licence are unsafe, and are causing serious—and...

New drugs aren't being properly tested for their safety or...

New 'breakthrough' drugs are often being allowed onto the market as safe and effective treatments with minimal evidence—and drug companies are failing to provide any good research even five years...

Statins raise type 2 diabetes risk by 60 per cent

  Cholesterol-lowering statins do raise the risk of type 2 diabetes, a major new review has confirmed. The risk can rise by as much as 60 per...
Indietro12Avanti
EMA - Events


Events

Third industry stakeholder platform on research and development support, European...

This third meeting between regulators and representatives of industry stakeholder organisations addresses all areas of product-development support, including scientific advice, specifics for paediatric and orphan medicines and support for innovation....

European Medicines Agency veterinary medicines innovation day, European Medicines Agency,...

The purpose of the European Medicines Agency (EMA) veterinary medicines innovation day is to raise awareness and promote the support and measures that the Agency has to offer in the...

Paediatric Committee (PDCO): 20-23 March 2018, European Medicines Agency, London,...

The Paediatric Committee (PDCO) is the committee that is responsible for assessing the content of paediatric investigation plans, which describe how a medicine should be studied in children, as well...
EMA - News and press releases


News and press releases

News and press releases: Meeting highlights from the Pharmacovigilance...

PRAC concludes two referrals, maintains recommendation on HES solutions for infusion and issues precautionary advice on HIV medicine

News and press releases: PRAC recommends new measures to...

Regular liver function testing required during treatment

News and press releases: EMA review of Zinbryta confirms...

Multiple sclerosis medicine no longer authorised and has been recalled from hospitals and pharmacies
EMA - Vacancies


Vacancies

Discontinuation of vacancies RSS feed - visit our Careers section

Please note that from January 2018, EMA will publish vacancy notices on its Jobs@EMA portal and will no longer update this vacancies RSS feed. For more information, please click on...